Welcome to the Psychedelic Science conference in Denver, Colorado!

In this episode, we delve into Daniel's background and his pivotal role at 'HMNC Brain Health'. We explore the mission and values of HMNC Brain Health, the origins of the company, and gain insight into the hypothalamus-pituitary-adrenal axis. We also discuss potential pharmacotherapy solutions for depression, the benefits that artificial intelligence may bring to therapy in the future, treatment-resistant patients, and HMNC's distinctive ketamine program. Additionally, we touch upon the skepticism faced by psychedelic therapies in European countries, Daniel's upcoming projects, and much more!

00:00 - Introduction

01:20 - The Founding Of HMNC

02:13 - Daniel's Role At HMNC Brain Health

04:16 - What HMNC Stand For, The HPA Axis

06:41 - Treatment-Resistant Patients

09:30 - Observations In My Community

11:50 - A Pharmacotherapy Solution

13:55 - Artificial Intelligence & Psychedelics

17:20 - Elon Musk's Neuralink

19:51 - The Ketamine Program

22:21 - Why Choose Ketamine?

23:35 - Skepticism In European Countries

26:01 - Daniel's Future Projects

28:35 - Outro

About Daniel:

Dr. Daniel Gehrlach is the associate director of biomarkers at HMNC Brain Health. After obtaining degrees in Pharmaceutical Biotechnology in Biberach and Medical Neurosciences at the Charité in Berlin, he completed his PhD at the Max Planck Institute of Neurobiology in Martinsried, Germany. He gained valuable experience in preclinical and translational in vivo models of affective disorders, in particular in the fields of anxiety, depression, and addiction. Daniel was awarded the Max Planck Institute’s ‘Young Scientist Award 2019’ for his doctoral project, which was also published in Nature Neuroscience. As associate director at HMNC Brain Health, he is the project lead for a Phase II clinical trial and leading the biomarker team.

Connect with Daniel:

Twitter: https://twitter.com/i/flow/login?redirect_after_login=%2Fdaniel_gehrlach

LinkedIn: https://www.linkedin.com/in/dr-daniel-gehrlach?utm_source=share&utm_campaign=share_via&utm_content=profile&utm_medium=ios_app

Thank you so much for joining us!

Psychedelic Conversations Podcast is designed to educate, inform, and expand awareness.

For more information, please head over to https://www.psychedelicconversations.com

Please share with your friends or leave a review so that we can reach more people and feel free to join us in our private Facebook group to keep the conversation going. https://www.facebook.com/groups/psychedelicconversations

This show is for information purposes only,

and is not intended to provide mental health or medical advice.

About Susan Guner:

Susan is a trained somatic, trauma-informed holistic psychotherapist with a mindfulness-based approach grounded in Transpersonal Psychology that focuses on holistic perspective through introspection, insight, and empathetic self-exploration to increase self-awareness, allowing the integration of the mind, body and spirit aspects of human experience in personal growth and development.

Connect with Susan:

Website: https://www.psychedelicconversations.com/

Facebook: http://www.facebook.com/susan.guner

LinkedIn: https://www.linkedin.com/in/susan-guner/

Instagram: http://www.instagram.com/susanguner

Twitter: http://www.twitter.com/susanguner

Blog: https://susanguner.medium.com/

Podcast: https://anchor.fm/susan-guner

#PsychedelicScience2023 #SusanGuner #DanielGehrlach